Discover 778 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 778
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Detroit MI, Cleveland OH, Dyer IN, Morgantown WV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Active & Responsive
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
for
Obesity, Heart Failure
Location: Maumee OH, Ypsilanti MI, Southfield MI,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07567001
Phase 3, Recruiting
Active & Responsive
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Location: Toledo OH, Flint MI, Morgantown WV, Joliet IL,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18+
Code: NCT01748903
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Alleviant ALLAY-HF Study
for
Heart Failure
Location: Toledo OH, Ann Arbor MI, Cleveland OH, Indianapolis IN,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 40+
Code: NCT05685303
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Toledo OH, Westlake OH, Columbus OH, Canton OH,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Toledo OH, Novi MI, Westlake OH, Cleveland OH,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Toledo OH, Allen Park MI, Windsor, Detroit MI,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
for
Type 2 Diabetes, Cardiovascular Risk
Location: Maumee OH, Troy MI, Flint MI, Hazel Crest IL, Gurnee IL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 45+
Code: NCT07797335
Phase 3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Ypsilanti MI, Ann Arbor MI, Rochester Hills MI,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
Prevail Global Study
for
Coronary Artery Disease
Location: Ypsilanti MI, Ann Arbor MI, Fort Wayne IN, Cleveland OH,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
Medtronic Cardiac Surgery PMCF Registry
for
Valve Disease, Heart
Location: Ann Arbor MI, Cleveland OH, Pittsburgh PA,
Sponsor: Medtronic Cardiac Surgery
Sex: All
Age: 0+
Code: NCT04073420
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
for
Solid Malignancies, Hematologic Malignancies
Location: Ann Arbor MI, Canton OH, Grand Rapids MI, Louisville KY,
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT06823167
Phase 1, Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for
Pulmonary Arterial Hypertension (PAH),
Location: Ann Arbor MI, Columbus OH, London, Washington D.C. DC,
Sponsor: AllRock Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07175038
Phase 2, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Ann Arbor MI, Columbus OH, Cincinnati OH, Buffalo NY,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Ann Arbor MI, Detroit MI, Cleveland OH, Dublin OH,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: Ann Arbor MI, Detroit MI, Cleveland OH, Dublin OH,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Ann Arbor MI, Detroit MI, Cleveland OH, Dublin OH,